Replimune (REPL) Current Assets (2018 - 2025)

Replimune has disclosed Current Assets across 8 years of filings, most recently posting $280.4 million for Q4 2025.

• Current Assets for Q4 2025 came in at $280.4 million, down 48.8% year-over-year; the trailing twelve-month figure through Dec 2025 was $280.4 million (down 48.8% YoY), and the FY2025 annual result was $495.9 million, up 14.35% from the prior year.
• Current Assets came in at $280.4 million for Q4 2025 at Replimune, down from $333.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $624.0 million in Q4 2022 to a low of $280.4 million in Q4 2025.
• The 5-year median for Current Assets is $454.5 million (2021), against an average of $459.4 million.
• Across the five-year window, Current Assets jumped 177.62% in 2021 and sank 48.8% in 2025, its largest moves.
• Replimune's Current Assets stood at $427.8 million in 2021, then surged by 45.86% to $624.0 million in 2022, then slipped by 23.21% to $479.2 million in 2023, then grew by 14.28% to $547.6 million in 2024, then tumbled by 48.8% to $280.4 million in 2025.
• The last three Current Assets figures came in at $280.4 million (Q4 2025), $333.7 million (Q3 2025), and $413.4 million (Q2 2025), per Business Quant data.